Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997-2017).
No Thumbnail Available
Identifiers
Date
2020-10-09
Authors
Beltrán-Pavez, Carolina
Gutiérrez-López, Miguel
Rubio-Garrido, Marina
Valadés-Alcaraz, Ana
Prieto, Luis
Ramos, José Tomás
Jiménez De Ory, Santiago
Navarro, Marisa
Díez-Romero, Cristina
Pulido, Federico
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
The aim of this transversal study was to describe the virological and immunological features of HIV-infected youths transferred from pediatric to adult care units since 1997 vs. the non-transferred patients from the Madrid Cohort of HIV-infected children and adolescents in Spain. We included 106 non-transferred and 184 transferred patients under clinical follow-up in 17 public hospitals in Madrid by the end of December 2017. Virological and immunological outcomes were compared in transferred vs. non-transferred patients. ART drug resistance mutations and HIV-variants were analyzed in all subjects with available resistance pol genotypes and/or genotypic resistance profiles. Among the study cohort, 133 (72.3%) of 184 transferred and 75 (70.7%) of 106 non-transferred patients had available resistance genotypes. Most (88.9%) of transferred had ART experience at sampling. A third (33.3%) had had a triple-class experience. Acquired drug resistance (ADR) prevalence was significantly higher in pretreated transferred than non-transferred patients (71.8% vs. 44%; p = 0.0009), mainly to NRTI (72.8% vs. 31.1%; p
Description
MeSH Terms
Adolescent
Adult
Anti-HIV Agents
Child
Child, Preschool
Cohort Studies
Drug Resistance, Viral
Female
Genotype
HIV Infections
HIV-1
Humans
Infant
Male
Mutation
Pediatrics
Spain
Viral Load
Young Adult
Adult
Anti-HIV Agents
Child
Child, Preschool
Cohort Studies
Drug Resistance, Viral
Female
Genotype
HIV Infections
HIV-1
Humans
Infant
Male
Mutation
Pediatrics
Spain
Viral Load
Young Adult